Tau Imaging in Professional Fighters
Status: | Completed |
---|---|
Conditions: | Alzheimer Disease |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/15/2017 |
Start Date: | December 2014 |
End Date: | February 3, 2017 |
18F-AV-1451 PET Imaging in Professional Fighters
Subjects enrolled in the Professional Fighters Brain Health Study (PFBHS) will receive
18F-AV-1451 to explore its use as a biomarker for brain injury related to repetitive head
trauma and to examine the relationship between clinical presentation and tau deposition.
18F-AV-1451 to explore its use as a biomarker for brain injury related to repetitive head
trauma and to examine the relationship between clinical presentation and tau deposition.
Inclusion Criteria:
All Subjects
- Currently enrolled in the PFBHS protocol and have participated in a minimum of 10
professional fights
- Can tolerate Positron Emission Tomography (PET) scan procedures
- Have the ability to provide informed consent
Subjects with cognitive impairment
- Have subjective cognitive complaints or objective decline or impairment as determined
by the investigator
Exclusion Criteria:
- Have behavior dysfunction that is likely to interfere with imaging
- Are claustrophobic or otherwise unable to tolerate the imaging procedure
- Have current clinically significant cardiovascular disease or clinically significant
abnormalities on screening electrocardiogram
- A history of additional risk factors for Torsades de Pointes (TdP) or are taking
drugs that are known to cause QT-prolongation
- Have a current clinically significant infectious disease, endocrine or metabolic
disease, pulmonary, renal or hepatic impairment, or cancer
- Have had a non-study related radiopharmaceutical imaging or treatment procedure
within 7 days prior to the study imaging session
- Have current drug or alcohol dependence or alcohol dependence within the past 2 years
We found this trial at
1
site
Click here to add this to my saved trials